Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy*

Author： Egom Emmanuel E.   Rose Robert A.   Neyses Ludwig   Soran Handrean   Cleland John G. F.   Mamas Mamas A.  

Publisher： Informa Healthcare

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.50, Iss.3, 2013-05, pp. : 79-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sphingosine‐1‐phosphate and renal vasoconstriction

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pleiotropic Effects and Cholesterol-Lowering Therapy

By  

Cardiology, Vol. 112, Iss. 1, 2008-06 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Sphingosine-1-phosphate synthesis and functions in mast cells

By Price Megan M   Oskeritzian Carole A   Milstien Sheldon   Spiegel Sarah  

Future Lipidology, Vol. 3, Iss. 6, 2008-12 ,pp. : 665-674

Future Medicine

Access to resources Recommend Favorite

Les récepteurs de la sphingosine 1-phosphate

By Cuvillier Olivier  

Médecine/sciences, Vol. 28, Iss. 11, 2012-11 ,pp. : 951-957

Edp Sciences

Access to resources Recommend Favorite

Role of sphingosine-1-phosphate receptor 1 and sphingosine-1-phosphate receptor 2 in hyperglycemia-induced endothelial cell dysfunction

By                      

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 1103-1108

Spandidos Publications

Access to resources Recommend Favorite